Production Of GlaxoSmithKline Plc's Ziagen HIV Oral Liquid Medicine

キーワード

A GlaxoSmithKline Canada Inc. employee labels and packages bottles of... ニュース写真アメリカ合州国,エイズ,カナダ,カナダ オンタリオ州,トロント,ヒト免疫不全ウィルス,ビジネス,ファイナンス,ミシサガ,ラベル,働く,包装,医療とヘルスケア,医薬品,南北アメリカ,口を使う,壜,本部,横長,法人企業,液体,職業Photographer Collection: Bloomberg 2010 BloombergA GlaxoSmithKline Canada Inc. employee labels and packages bottles of Ziagen, an HIV oral liquid medication, on the packaging line at the company's Canadian headquarters in Mississauga, Ontario, Canada, on Monday, Dec. 13, 2010. Global sales of existing HIV medicines will peak at $12 billion in 2012, then halve by 2019 as patent expiries increase competition from generic drugs, according to a report by Datamonitor Group earlier this year. Photographer: Norm Betts/Bloomberg via Getty Images